Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies
Authors:
Open Access
- 6 November 2023
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 232, 77-88
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- The gastrointestinal mucus system in health and diseaseNature Reviews Gastroenterology & Hepatology, 2013
- Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatmentGenome Biology, 2012
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular trapsJournal of Experimental Medicine, 2010
- Serum albumin and risk of venous thromboembolismThrombosis and Haemostasis, 2010
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeabilityGut, 2009
- Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole bloodThrombosis Journal, 2007
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences, 2007
- Evidence of Toll‐like receptor molecules on human plateletsImmunology & Cell Biology, 2005